| 注册
首页|期刊导航|中国中医药信息杂志|中药干预乳腺癌血管生成双途径研究进展

中药干预乳腺癌血管生成双途径研究进展

刘秋雨 连增林

中国中医药信息杂志2017,Vol.24Issue(2):120-126,7.
中国中医药信息杂志2017,Vol.24Issue(2):120-126,7.DOI:10.3969/j.issn.1005-5304.2017.02.033

中药干预乳腺癌血管生成双途径研究进展

Research Progress in TCM Intervention in Duel Pathways of Breast Cancer Angiogenesis

刘秋雨 1连增林2

作者信息

  • 1. 汉典集团北京汉典中医研究院,北京 100176
  • 2. 北京中医药大学中药学院,北京 100102
  • 折叠

摘要

Abstract

Tumor neovascularization and vasculogenic mimicry are two important angiogenesis pathways, which play an important role in the occurrence, development and metastasis of breast cancer. TCM has confirmed efficacy in the prevention and treatment of breast cancer. In recent years, research on inhibition of tumor angiogenesis is also gradually in-depth. This article reviewed the progress of TCM in the dual pathways of breast cancer angiogenesis and its mechanism, and provided references for clinical medication and research and development of new medicine.

关键词

乳腺癌/肿瘤新生血管/血管生成拟态/中药/综述

Key words

breast cancer/tumor neovascularization/vasculogenic mimicry/TCM/review

分类

医药卫生

引用本文复制引用

刘秋雨,连增林..中药干预乳腺癌血管生成双途径研究进展[J].中国中医药信息杂志,2017,24(2):120-126,7.

中国中医药信息杂志

OACSCDCSTPCD

1005-5304

访问量0
|
下载量0
段落导航相关论文